Name | Number of supported studies | Average coverage | |
---|---|---|---|
ciliated cell | 12 studies | 29% ± 11% | |
epithelial cell | 5 studies | 28% ± 12% | |
macrophage | 3 studies | 18% ± 2% | |
dendritic cell | 3 studies | 28% ± 3% |
Insufficient scRNA-seq data for expression of ADPRS at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1727.33 | 1445 / 1445 | 100% | 41.92 | 183 / 183 |
liver | 100% | 892.56 | 226 / 226 | 100% | 45.87 | 406 / 406 |
ovary | 100% | 1429.52 | 180 / 180 | 100% | 92.13 | 430 / 430 |
pancreas | 100% | 759.50 | 328 / 328 | 100% | 74.10 | 178 / 178 |
skin | 100% | 2225.04 | 1809 / 1809 | 100% | 103.09 | 472 / 472 |
thymus | 100% | 1602.45 | 653 / 653 | 100% | 102.02 | 605 / 605 |
uterus | 100% | 1495.71 | 170 / 170 | 100% | 116.22 | 459 / 459 |
brain | 100% | 1368.81 | 2636 / 2642 | 100% | 81.52 | 705 / 705 |
kidney | 100% | 1852.40 | 89 / 89 | 100% | 83.51 | 898 / 901 |
adrenal gland | 100% | 2622.39 | 258 / 258 | 100% | 59.81 | 229 / 230 |
intestine | 100% | 1401.43 | 966 / 966 | 99% | 62.54 | 523 / 527 |
prostate | 100% | 1589.74 | 245 / 245 | 99% | 76.79 | 498 / 502 |
lung | 99% | 1678.57 | 575 / 578 | 100% | 75.40 | 1151 / 1155 |
breast | 100% | 1479.06 | 459 / 459 | 99% | 82.41 | 1108 / 1118 |
bladder | 100% | 1636.33 | 21 / 21 | 99% | 92.05 | 499 / 504 |
stomach | 100% | 1063.63 | 358 / 359 | 99% | 50.93 | 283 / 286 |
adipose | 100% | 1432.74 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1324.53 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 68.42 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 98.15 | 29 / 29 |
muscle | 100% | 1488.89 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 1749.35 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 99.38 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 109.70 | 1 / 1 |
heart | 98% | 866.03 | 847 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 96% | 1420.70 | 894 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0140290 | Biological process | peptidyl-serine ADP-deribosylation |
GO_0006281 | Biological process | DNA repair |
GO_0060546 | Biological process | negative regulation of necroptotic process |
GO_0071451 | Biological process | cellular response to superoxide |
GO_0006287 | Biological process | base-excision repair, gap-filling |
GO_0090734 | Cellular component | site of DNA damage |
GO_0016604 | Cellular component | nuclear body |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005759 | Cellular component | mitochondrial matrix |
GO_0005737 | Cellular component | cytoplasm |
GO_0005739 | Cellular component | mitochondrion |
GO_0005634 | Cellular component | nucleus |
GO_0004649 | Molecular function | poly(ADP-ribose) glycohydrolase activity |
GO_0140292 | Molecular function | ADP-ribosylserine hydrolase activity |
GO_0061463 | Molecular function | O-acetyl-ADP-ribose deacetylase activity |
GO_0004553 | Molecular function | hydrolase activity, hydrolyzing O-glycosyl compounds |
GO_0005515 | Molecular function | protein binding |
GO_0000287 | Molecular function | magnesium ion binding |
Gene name | ADPRS |
Protein name | ADP-ribosylhydrolase ARH3 (EC 3.2.1.143) (ADP-ribose glycohydrolase ARH3) (ADP-ribosylhydrolase 3) (O-acetyl-ADP-ribose deacetylase ARH3) (Poly(ADP-ribose) glycohydrolase ARH3) ([Protein ADP-ribosylarginine] hydrolase-like protein 2) ([Protein ADP-ribosylserine] hydrolase) ADP-ribosylhydrolase ARH3 (ADP-ribose glycohydrolase ARH3) (ADP-ribosylhydrolase 3) (O-acetyl-ADP-ribose deacetylase ARH3) (EC 3.5.1.-) (Poly(ADP-ribose) glycohydrolase ARH3) (EC 3.2.1.143) ([Protein ADP-ribosylarginine] hydrolase-like protein 2) ([Protein ADP-ribosylserine] hydrolase) (EC 3.2.2.-) |
Synonyms | ARH3 hCG_38289 ADPRHL2 |
Description | FUNCTION: ADP-ribosylhydrolase that preferentially hydrolyzes the scissile alpha-O-linkage attached to the anomeric C1'' position of ADP-ribose and acts on different substrates, such as proteins ADP-ribosylated on serine and threonine, free poly(ADP-ribose) and O-acetyl-ADP-D-ribose . Specifically acts as a serine mono-ADP-ribosylhydrolase by mediating the removal of mono-ADP-ribose attached to serine residues on proteins, thereby playing a key role in DNA damage response . Serine ADP-ribosylation of proteins constitutes the primary form of ADP-ribosylation of proteins in response to DNA damage . Does not hydrolyze ADP-ribosyl-arginine, -cysteine, -diphthamide, or -asparagine bonds . Also able to degrade protein free poly(ADP-ribose), which is synthesized in response to DNA damage: free poly(ADP-ribose) acts as a potent cell death signal and its degradation by ADPRHL2 protects cells from poly(ADP-ribose)-dependent cell death, a process named parthanatos . Also hydrolyzes free poly(ADP-ribose) in mitochondria . Specifically digests O-acetyl-ADP-D-ribose, a product of deacetylation reactions catalyzed by sirtuins . Specifically degrades 1''-O-acetyl-ADP-D-ribose isomer, rather than 2''-O-acetyl-ADP-D-ribose or 3''-O-acetyl-ADP-D-ribose isomers . . |
Accessions | ENST00000373178.5 Q9NX46 B7ZAN4 |